MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms-Reference-Cited by-同舟云学术

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms

Published:2011-09-20 Issue:2 Volume:13 Page:137-147
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Owen S A,Lunt M,Bowes J,Hider S L,Bruce I N,Thomson W,Barton A

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201142.pdf

Reference63 articles.

1. Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985; 312: 818–822.

2. Williams HJ, Willkens RF, Samuelson Jr CO, Alarcon GS, Guttadauria M, Yarboro C et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1985; 28: 721–730.

3. Le Loet X, Berthelot JM, Cantagrel A, Combe B, De Bandt M, Fautrel B et al. Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology. Ann Rheum Dis 2006; 65: 45–50.

4. Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Lund Hetland M et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007; 66: 1491–1496.

5. Alarcon GS, Tracy IC, Blackburn Jr WD . Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 1989; 32: 671–676.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis;Frontiers in Pharmacology;2022-11-17

2. Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine;Diagnostics;2022-06-27

3. Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis;Methods in Molecular Biology;2022

4. A review of liquid biopsy as a tool to assess epigenetic, cfDNA and miRNA variability as methotrexate response predictors in patients with rheumatoid arthritis;Pharmacological Research;2021-11

5. Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis;Journal of Clinical Medicine;2021-09-09